This legal action highlights the critical tension between government transparency and public health accountability. America First Legal is suing the FDA for failing to disclose records regarding the off-label use of puberty blockers and cross-sex hormones on minors. The lawsuit argues that this concealment violates the Freedom of Information Act, depriving citizens of essential data needed to evaluate the agency’s compliance with safety regulations. The case underscores the importance of access to medical policy details, especially when treatments lack formal approval for specific pediatric uses. Critics describe these hormones as experimental, citing potential severe health risks and long-term complications. By seeking this information, the plaintiffs aim to shed light on practices that may constitute dangerous experimentation, contrasting current US trends with regulatory retreats in other nations. For the open data community, this story illustrates how FOIA requests serve as a primary mechanism for revealing hidden institutional behaviors. It emphasizes that accessible, unredacted government records are vital for holding agencies accountable and ensuring an informed electorate. Without robust open data practices and legal enforcement of transparency laws, the public remains unaware of significant healthcare decisions affecting vulnerable populations.
Source: foxnews.comPublished on 2023-03-01
Related news
- Two Norwalk Dems allege Council majority violates open meeting laws
- Public Records Request Nets User's Manual For Palantir's Souped-Up Surveillance Software
- Número de defunciones en el país sigue alto: Inegi
- JPMorgan is scapegoating her with its fraud suit, Frank founder says
- Shedding light on rare diseases: open data and model organisms